Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-25-036117
Filing Date
2025-07-28
Accepted
2025-07-28 11:07:08
Documents
15
Period of Report
2025-07-28

Document Format Files

Seq Description Document Type Size
1 6-K cybin-agmmaterialsform6xk.htm 6-K 14374
2 EX-99.1 agm2025-managementinformat.htm EX-99.1 514344
3 EX-99.2 agm2025-abridgementcertifi.htm EX-99.2 7492
4 EX-99.3 asm2025-formofproxycybin.htm EX-99.3 6521
5 EX-99.4 agm2025-noticeofmeeting.htm EX-99.4 13363
6 GRAPHIC asm2025-formofproxycybin001.jpg GRAPHIC 165079
7 GRAPHIC asm2025-formofproxycybin002.jpg GRAPHIC 192478
8 GRAPHIC image_0a.jpg GRAPHIC 38349
9 GRAPHIC image_1a.jpg GRAPHIC 43598
10 GRAPHIC image_2a.jpg GRAPHIC 57515
11 GRAPHIC image_3a.jpg GRAPHIC 139631
12 GRAPHIC image_4a.jpg GRAPHIC 133883
13 GRAPHIC image_5a.jpg GRAPHIC 155533
14 GRAPHIC image_6a.jpg GRAPHIC 166926
15 GRAPHIC image_7a.jpg GRAPHIC 102644
  Complete submission text file 0001628280-25-036117.txt   2205032
Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Filer) CIK: 0001833141 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-40673 | Film No.: 251154253
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)